324 related articles for article (PubMed ID: 1982834)
1. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
2. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
[TBL] [Abstract][Full Text] [Related]
3. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
Icardi A; Paoletti E; Molinelli G
Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
[TBL] [Abstract][Full Text] [Related]
5. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
Miranda B; Selgas R; Riñon C; Fernandez-Zamorano A; Borrego F; Ortuño F; Lopez-Revuelta K; Torre A; Sanchez Sicilia L
Adv Perit Dial; 1990; 6():296-301. PubMed ID: 1982831
[TBL] [Abstract][Full Text] [Related]
6. The use of subcutaneous erythropoietin in CAPD patients.
Piraino B; Johnston JR
Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
[TBL] [Abstract][Full Text] [Related]
7. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
Litwin M; Boguszewska-Baczkowska A; Jelonek A
Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
[TBL] [Abstract][Full Text] [Related]
8. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
9. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
Bunke M; Bartlett DK; Brier ME; Golper TA
Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
14. Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patients.
Carozzi S; Ramello A; Nasini MG; Schelotto C; Caviglia PM; Cantaluppi A; Salit M; Lamperi S
Adv Perit Dial; 1990; 6():312-5. PubMed ID: 1982836
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of and tolerance to human recombinant erythropoietin in the treatment of kidney failure anemia in children undergoing continuous peritoneal dialysis. Multicenter study].
Parchoux B; Broyer M; Cochat P; Burguet A; Menget A; Benoît D; Nivet H; Fischbach M; Geisert J; Dabout D
Pediatrie; 1993; 48(5):397-401. PubMed ID: 7777395
[TBL] [Abstract][Full Text] [Related]
16. [Chronic kidney failure, anemia and erythropoietin].
Sulková S
Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
[TBL] [Abstract][Full Text] [Related]
17. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
18. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
Hussein MM; Mooij JM; Roujouleh H
Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
[No Abstract] [Full Text] [Related]
20. Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietin.
Conlon PJ; O'Neill S; O'Neill G; Kelly F; Donohoe J
Clin Nephrol; 1994 Feb; 41(2):83-5. PubMed ID: 8004833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]